Selpercatinib
Selpercatinib | |
---|---|
Term | Selpercatinib |
Short definition | Selpercatinib - (pronounced) (SEL-per-KA-tih-nib) drug used to treat certain types of non-small cell lung cancer or other solid tumors in adults and certain types of thyroid cancer in adults and children 12 years and older that are caused by an abnormal RET gene. It is also being studied in the treatment of other types of cancer. |
Type | Cancer terms |
Specialty | Oncology |
Language | English |
Source | NCI |
Comments |
Selpercatinib - (pronounced) (SEL-per-KA-tih-nib) drug used to treat certain types of non-small cell lung cancer or other solid tumors in adults and certain types of thyroid cancer in adults and children 12 years and older that are caused by an abnormal RET gene. It is also being studied in the treatment of other types of cancer. Selpercatinib blocks certain proteins, including those made by the RET fusion gene or the mutated RET gene. Blocking these proteins can help prevent cancer cells from growing. Selpercatinib is a type of tyrosine kinase inhibitor. Also called Retevmo
External links
- Medical encyclopedia article on Selpercatinib
- Wikipedia's article - Selpercatinib
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski